Treatments

US judge rules against blocking Medicare from negotiating drug prices

Mon, 2023-10-02 07:19 — mike kraft

US judge refuses to block Medicare from negotiating drug prices | Reuters

Sept 29 (Reuters) - The U.S. government's Medicare health insurance program can begin negotiating prices for some prescription drugs this fall under a new program, a federal judge ruled on Friday, vindicating one of President Joe Biden's signature initiatives.

The order by U.S. District Judge Michael Newman in Dayton, Ohio, comes in a lawsuit brought against the Biden administration by the U.S. Chamber of Commerce.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about US judge rules against blocking Medicare from negotiating drug prices
Log in or register to post comments

Helping determine if it is a cold, flu or Covid-19 -A CNN medical consultant's suggestions

Fri, 2023-09-29 08:01 — mike kraft

Is it cold, the flu or Covid-19? A doctor helps sort it out | CNN As more people start getting the sniffles, you may wonder if it’s a cold, the flu or Covid-19? Dr. Leana Wen helps us sort out those cold-like symptoms and decide what to do next. Katia Hetter CNN

...

Dr. Wen:

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Other

Read more about Helping determine if it is a cold, flu or Covid-19 -A CNN medical consultant's suggestions
Log in or register to post comments

Status of Legal Liability of U.S. Healthcare Providers for Care Provided During COVID-19 Pandemic

Thu, 2023-09-28 08:33 — mike kraft

Legal Liability of Healthcare Providers for Care Provided During COVID-19 Pandemic

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Status of Legal Liability of U.S. Healthcare Providers for Care Provided During COVID-19 Pandemic
Log in or register to post comments

U.S. Government program to develop the next generation of Covid vaccines makes $433 million research grant

Wed, 2023-09-27 15:42 — mike kraft

U.S. government’s next-gen Covid effort gives small biotech up to $433 million The U.S. government said it would give a small biotechnology firm, Gritstone bio, up to $433 million to conduct a 10,000-volunteer clinical trial testing a new approach to creating a Covid vaccine. Matthew Herper STAT

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Advice for Americans on how to get the new COVID vaccine for free, with or without insurance

Tue, 2023-09-26 07:13 — mike kraft

How to get the new COVID vaccine for free, with or without insurance Americans still have ways to get vaccinated against COVID-19 at no out-of-pocket cost. Here's what to know. Yahoo Life

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Solutions

Situation Report

Read more about Advice for Americans on how to get the new COVID vaccine for free, with or without insurance
Log in or register to post comments

A new season of infections is here, but the shortage of a common kids’ antibiotic never ended

Mon, 2023-09-25 12:59 — FNUOvviyaa

A new season of infections is here, but the shortage of a common kids’ antibiotic never ended | CNN Parents across the US are beginning to face the struggles of a second winter without enough supplies of amoxicillin, the most prescribed antibiotic in the country. Brenda Goodman CNN

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Problem

Read more about A new season of infections is here, but the shortage of a common kids’ antibiotic never ended
Log in or register to post comments

Both Paxlovid, molnupiravir lower COVID Omicron deaths, hospitalizations -- studies

Fri, 2023-09-22 07:17 — mike kraft

Both Paxlovid, molnupiravir lower COVID Omicron deaths, hospitalizations, studies conclude AsiaVision / iStock CIDRAP

Two new studies describe the benefits of the antiviral drugs nirmatrelvir-ritonavir (Paxlovid) and molnupiravir in reducing SARS-CoV-2 Omicron hospitalizations and death, with one finding that the former is more effective than the latter at lowering death rates.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Both Paxlovid, molnupiravir lower COVID Omicron deaths, hospitalizations -- studies
Log in or register to post comments

Depressant fluvoxamine not effective in reducing COVID inflammation--study

Tue, 2023-09-19 16:43 — mike kraft

Study shows no benefits of antidepressant for COVID-19 symptoms - UPI.com Researchers studied fluvoxamine because previous evidence suggested that it might be able to reduce inflammation caused by the virus. UPI

A clinical trial designed to test repurposed medications for their impact on fighting COVID-19 has found no benefit to taking the antidepressant fluvoxamine (Luvox) to ease coronavirus symptoms.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis